BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 8607870)

  • 1. The role of calpastatin (the specific calpain inhibitor) in myoblast differentiation and fusion.
    Barnoy S; Glasner T; Kosower NS
    Biochem Biophys Res Commun; 1996 Mar; 220(3):933-8. PubMed ID: 8607870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpain and calpastatin in myoblast differentiation and fusion: effects of inhibitors.
    Barnoy S; Glaser T; Kosower NS
    Biochim Biophys Acta; 1997 Sep; 1358(2):181-8. PubMed ID: 9332454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The calpain-calpastatin system and protein degradation in fusing myoblasts.
    Barnoy S; Glaser T; Kosower NS
    Biochim Biophys Acta; 1998 Mar; 1402(1):52-60. PubMed ID: 9551085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of calpastatin inhibits L8 myoblast fusion.
    Barnoy S; Maki M; Kosower NS
    Biochem Biophys Res Commun; 2005 Jul; 332(3):697-701. PubMed ID: 15904894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of calpain (Ca(2+)-dependent thiol protease) with its endogenous inhibitor calpastatin in myoblasts.
    Barnoy S; Zipser Y; Glaser T; Grimberg Y; Kosower NS
    J Cell Biochem; 1999 Sep; 74(4):522-31. PubMed ID: 10440922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-1-induced calpastatin degradation in myoblast differentiation and fusion: cross-talk between the caspase and calpain systems.
    Barnoy S; Kosower NS
    FEBS Lett; 2003 Jul; 546(2-3):213-7. PubMed ID: 12832042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of calpain and calpastatin in differentiating myoblasts: mRNA levels, protein synthesis and stability.
    Barnoy S; Supino-Rosin L; Kosower NS
    Biochem J; 2000 Oct; 351 Pt 2(Pt 2):413-20. PubMed ID: 11023827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoblast migration is regulated by calpain through its involvement in cell attachment and cytoskeletal organization.
    Dedieu S; Poussard S; Mazères G; Grise F; Dargelos E; Cottin P; Brustis JJ
    Exp Cell Res; 2004 Jan; 292(1):187-200. PubMed ID: 14720518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpastatin-modulation of m-calpain activity is required for myoblast fusion.
    Balcerzak D; Cottin P; Poussard S; Cucuron A; Brustis JJ; Ducastaing A
    Eur J Cell Biol; 1998 Mar; 75(3):247-53. PubMed ID: 9587056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calpastatin in rat myoblasts: transient diminution and decreased phosphorylation depend on myogenin-directed myoblast differentiation.
    Barnoy S; Kosower NS
    Int J Biochem Cell Biol; 2007; 39(1):253-61. PubMed ID: 16997608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microinjection of calpastatin inhibits fusion in myoblasts.
    Temm-Grove CJ; Wert D; Thompson VF; Allen RE; Goll DE
    Exp Cell Res; 1999 Feb; 247(1):293-303. PubMed ID: 10047471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calpastatin (the endogenous calpain inhibitor) and membrane protein degradation in cell fusion.
    Kosower NS; Barnoy S
    Methods Mol Biol; 2000; 144():181-94. PubMed ID: 10818763
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential m-calpain substrates during myoblast fusion.
    Dourdin N; Balcerzak D; Brustis JJ; Poussard S; Cottin P; Ducastaing A
    Exp Cell Res; 1999 Feb; 246(2):433-42. PubMed ID: 9925759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain-calpastatin and fusion. Fusibility of erythrocytes is determined by a protease-protease inhibitor [calpain-calpastatin] balance.
    Glaser T; Kosower NS
    FEBS Lett; 1986 Sep; 206(1):115-20. PubMed ID: 3019763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat myoblast fusion requires exteriorized m-calpain activity.
    Brustis JJ; Elamrani N; Balcerzak D; Safwate A; Soriano M; Poussard S; Cottin P; Ducastaing A
    Eur J Cell Biol; 1994 Aug; 64(2):320-7. PubMed ID: 7813519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis stimulates calpain activity in skeletal muscle by decreasing calpastatin activity but does not activate caspase-3.
    Wei W; Fareed MU; Evenson A; Menconi MJ; Yang H; Petkova V; Hasselgren PO
    Am J Physiol Regul Integr Comp Physiol; 2005 Mar; 288(3):R580-90. PubMed ID: 15563579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoblot analysis of calpastatin degradation: evidence for cleavage by calpain in postmortem muscle.
    Doumit ME; Koohmaraie M
    J Anim Sci; 1999 Jun; 77(6):1467-73. PubMed ID: 10375223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of two calpastatin forms in rat skeletal muscle and their susceptibility to digestion by homologous calpains.
    Pontremoli S; Melloni E; Viotti PL; Michetti M; Salamino F; Horecker BL
    Arch Biochem Biophys; 1991 Aug; 288(2):646-52. PubMed ID: 1898054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells.
    Murray SS; Grisanti MS; Bentley GV; Kahn AJ; Urist MR; Murray EJ
    Exp Cell Res; 1997 Jun; 233(2):297-309. PubMed ID: 9194492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Ca2+ on binding of the calpains to calpastatin.
    Kapprell HP; Goll DE
    J Biol Chem; 1989 Oct; 264(30):17888-96. PubMed ID: 2553696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.